Cargando…
Parkinson’s disease, treatment choice and survival over time
OBJECTIVES: We compared Monoamine oxidase B (MAO-B) – and dopamine agonist (DA) monotherapy patients with respect to survival, considering gender, age, first prescriber’s specialty and relevant co-morbidity, and compared their specialist health care contacts and hospitalizations. METHODS: With data...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816715/ https://www.ncbi.nlm.nih.gov/pubmed/35146410 http://dx.doi.org/10.1016/j.prdoa.2022.100136 |